Overexpression, Purification, and Characterization of the Catalase-peroxidase KatG from Mycobacterium tuberculosis*

(Received for publication, September 17, 1996, and in revised form, November 13, 1996)

Kai Johnsson Dagger §, Wayne A. Froland and Peter G. Schultz par

From the Howard Hughes Medical Institute, Department of Chemistry, University of California, Berkeley, California 94720

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgments
REFERENCES


ABSTRACT

Wild-type catalase-peroxidase KatG from Mycobacterium tuberculosis as well as a specific mutant (R463L) frequently found in isoniazid-resistant strains have been overexpressed in Escherichia coli, allowing purification of sufficient quantities of enzyme for physical and kinetic characterization. Optical absorption and EPR spectroscopies indicate that KatG is similar to a growing class of bacterial catalase-peroxidases. Optical and EPR spectra of KatG in the presence of either a strong field or weak field ligand suggest that, like horseradish peroxidase and metmyoglobin, KatG is likely to have a histidine as a proximal ligand. The wild-type enzyme functions as a highly active catalase as well as a broad specificity peroxidase. Wild-type KatG and the R463L mutant of KatG exhibit identical spectroscopic and kinetic properties. Furthermore, both enzymes are equally capable of metabolizing the important antituberculosis drug isoniazid.


INTRODUCTION

Tuberculosis is a reemerging disease in the industrialized world and continues to be the single most deadly infectious disease in developing countries (1, 2). The emergence of multidrug-resistant strains of Mycobacterium tuberculosis (3) and the widening association of mycobacterial infection and AIDS (4) have underscored the need for research into the mechanisms of drug resistance and the design of more effective antimycobacterial agents (1). Introduced in 1952, isoniazid (isonicotinic acid hydrazide) is still the most widely used antituberculosis drug. Despite its importance, it has only been in the last few years, with the development of mycobacterial genetics, that an understanding of its mechanism of action has advanced (5). Analysis of isoniazid-resistant strains revealed that isoniazid is oxidized to its activated form by a mycobacterial catalase-peroxidase (KatG) (6). The ultimate target of the activated drug may either be an enoyl-acyl carrier protein reductase (InhA), an enzyme involved in mycolic acid biosynthesis (7, 8), or an as yet unidentified alternative target involved in the biosynthesis of long chain fatty acids (9). A more detailed analysis of the reaction of isoniazid with KatG has shown that the reaction proceeds through a number of highly reactive intermediates, including radical and electrophilic species (10, 11). More recently, we have demonstrated that one of these reactive intermediates specifically reacts with InhA to form a relatively stable 1:1 enzyme-inhibitor complex (12).

The mycobacterial enzyme KatG belongs to a growing class of bacterial enzymes referred to as either hydroperoxidases I or catalase-peroxidases (13). Members of this class have been isolated from a variety of different bacteria including Escherichia coli B (14), Bacillus stearothermophilus (15), Klebsiella pneumoniae (16), Halobacterium halobium (17), Rhodobacter capsulatas B10 (18, 19), Streptomyces sp. IMSNU-1 (20), Haloarcula marismortui (21), Bacillus strain YN-2000 (22), Synechococcus PCC 7942 (23), Penicillium simplicissimum (24), Mycobacterium smegmatis (25), and M. tuberculosis (26, 27, 55). However, no detailed studies on the kinetic and spectroscopic properties of the M. tuberculosis enzyme have been reported. Hydroperoxidases I are heme enzymes that have both catalase and peroxidase activities (Fig. 1). The ratio of catalase to peroxidase activity, however, varies among different members of this class. The physiological role of the bacterial catalase-peroxidases is believed to be as a response to oxidative stress arising from the continuous metabolic generation of reactive oxygen byproducts or environmental factors. In M. tuberculosis, which resides within host macrophages, KatG is also an important virulence factor, since it can detoxify reactive oxygen species generated by the macrophage and cellular components damaged by these species (28, 29).


Fig. 1. Proposed reaction pathways of catalase-peroxidases.
[View Larger Version of this Image (11K GIF file)]


It is thought that KatG is the only enzyme in M. tuberculosis capable of generating isoniazid susceptibility and that it therefore plays a central role in the development of at least one type of isoniazid resistance (6). Total or partial deletion of the katG gene, as well as mutations that render KatG inactive, all lead to isoniazid resistance (13, 30, 31).1 In addition, a mutation in KatG (R463L), which does not lead to a loss of peroxidase or catalase activity (30), is also thought to confer isoniazid resistance. This mutation has been identified in about 30-50% of all isoniazid-resistant clinical strains analyzed thus far but very rarely in isoniazid-susceptible strains (30-34, 53). It has been suggested that residue 463 might interact with the substrate binding site of KatG and that Leu463 might discriminate against isoniazid (30). Furthermore, it has been found that both Mycobacterium intracellulare, which is naturally resistant to isoniazid, and Mycobacterium bovis BCG, which is less sensitive to isoniazid than M. tuberculosis, possess a leucine residue at position 463 of KatG (30). However, it has recently been shown that expression of either wild-type KatG or the KatG R463L mutant in an isoniazid-resistant, KatG-defective M. smegmatis strain both confer isoniazid sensitivity to about the same extent (31). It is evident from these results that a clear relationship between the KatG R463L mutant and isoniazid resistance has not yet been established. We describe here the subcloning of katG from M. tuberculosis into an E. coli expression vector, the overexpression and purification of the enzyme, and its kinetic and spectroscopic characterization. Furthermore, we report the generation and characterization of the R463L mutant of KatG, including its in vitro activity toward isoniazid and its capability to mediate the inactivation of InhA.


EXPERIMENTAL PROCEDURES

Materials

Plasmid pYZ55 containing katG was provided by Dr. Stewart Cole (Pasteur Institute) (6). E. coli strain UM262 (recA katG::Tn10 pro leu rpsL hsdM hsdR endl lacY) was provided by Dr. Richard Loewen (University of Manitoba) (35). pRG (36) was provided by Dr. Sung-Ho Kim (University of California, Berkeley). Purified InhA was provided by Dr. John Blanchard (Albert Einstein College of Medicine) (8). Restriction enzymes and T4 DNA ligase were obtained from New England Biolabs, Inc. Sequenase was obtained from Amersham Life Science Inc. Taq DNA polymerase was obtained from Promega. Isoniazid was obtained from Aldrich and was recrystallized from ethanol. All synthetic DNA oligomers were synthesized with an Applied Biosystems 391 DNA synthesizer. All other chemicals were the highest quality available and used without further purification.

Subcloning Methods

The katG coding region of pYZ55 was amplified by polymerase chain reaction using the following primers: 5'-GGA GAT ATA TCG ATG CCC GAA CAA CCA CCC ATT ACA GAA-3', consisting of a ClaI restriction site followed by the sequence encoding the 10 N-terminal amino acids of KatG; and 5'-CAG GTC AAG AAG CTT TCA GCG CAC GTC GAA CCT GTC GAG GTT-3', consisting of the final eight C-terminal amino acids of KatG and a TGA termination codon followed by a HindIII restriction site. The gel-purified polymerase chain reaction product was digested with ClaI and HindIII, yielding a 526-base pair ClaI/ClaI fragment and a 1.68-kilobase pair ClaI/HindIII fragment. The fragments were ligated into the plasmid pRG (36), also digested with ClaI and HindIII, yielding the plasmid pKAT. Sequencing of pKAT indicated that two mutations had been introduced by polymerase chain reaction. To correct these mutations, pYZ55 was digested with NsiI and NheI, yielding a 2.4-kilobase pair NheI/NsiI fragment that extends over the termination codon of the coding region of katG. pKAT was digested with NheI and HindIII, and the digested plasmid was gel-purified. The NheI/NsiI fragment and a NsiI/HindIII double-stranded oligomer (containing an internal KpnI site) were ligated into the digested plasmid. The resulting plasmid pKATII was used to transform competent E. coli UM262. The transformants were screened for the KpnI site, and the sequence of the gene was subsequently verified. An AflII site at Leu458 and a BsmAI site at Val469 allowed the introduction of a synthetic oligonucleotide 5'-TT AAG AGC CAG ATC CTG GCA TCG GGT CTC ACT GTC TCA-3' bearing the mutation R463L. Introduction of the mutation R463L was confirmed by sequencing.

Bacterial Growth and Purification of the Catalase-Peroxidase KatG

E. coli UM262 pKATII and E. coli UM262 pKATII R463L were grown in M9 medium (Sigma) supplemented with 50 µg/ml Fe(NH4)2(SO4)2. Bacterial growths were typically done on a 6-liter scale (6 × 1 liter) at 37 °C with vigorous agitation and were induced at midlog phase by the addition of beta -indolacrylic acid (40 mg/liter). Cells were grown for an additional 10 h after induction and collected by centrifugation. All of the following purification procedures were performed at 0-4 °C. Cells were lysed with DNase I according to standard procedures (37). Solid (NH4)2SO4 was added to the crude cell lysate to make a 40% saturated solution at 4 °C. After 15 min, the solution was centrifuged at 12,000 × g for 30 min. The KatG activity was precipitated by the addition of solid (NH4)2SO4 to the supernatant to make a 65% saturated solution. The precipitated protein was collected by centrifugation, and the protein pellet was dissolved in 20 mM bis-Tris, pH 7.0, (approximately 20 ml) and desalted with a Sephadex G-25 column (27 × 400 mm) equilibrated in the same buffer. Fractions containing protein were pooled, diluted to 100 ml with 20 mM Bis-Tris, pH 7.0, and applied to a similarly equilibrated DEAE-Sephacel column (27 × 170 mm). The absorbed protein was eluted with a 1100-ml gradient from 0 to 0.5 M NaCl at a linear flow rate of 16 cm/h. Fractions containing KatG typically eluted at approximately 0.2 M NaCl. Those fractions with an A280/A406 ratio of less than 2.8 were pooled, and the pooled protein was concentrated by the addition of solid (NH4)2SO4 to make a 70% saturated solution at 4 °C. After 20 min, the precipitated protein was collected by centrifugation at 30,000 × g for 30 min. The protein pellet was dissolved in 5 ml of 20 mM bis-Tris, pH 7, 150 mM NaCl, and the residual (NH4)2SO4 was removed utilizing a PD10 desalting column (Pharmacia Biotech Inc.). The desalted solution was applied to a Superdex S200 column (27 × 700 mm) equilibrated with 20 mM bis-Tris, pH 7.0, 150 mM NaCl and eluted at a linear flow rate of 19 cm/h. Fractions with an A280/A406 ratio of less than 2.1 were pooled, and the protein was concentrated with (NH4)2SO4 as described above. The protein was dissolved in 2-3 ml of 20 mM Tris, pH 7.6, and the residual ammonium sulfate was removed as described above. The solution was diluted to 10 ml with 20 mM Tris, pH 7.6, and applied to a similarly equilibrated HR 10/10 Mono Q column (Pharmacia) (2.5 ml/run). Protein was eluted utilizing a 160-ml linear gradient from 0 to 0.28 M NaCl. Fractions with an A280/A406 ratio of less than 1.45 were pooled, and the protein was concentrated with (NH4)2SO4 as described above. The precipitated protein was dissolved in 20 mM MOPS,2 pH 7.5, containing 40% glycerol and stored at -80 °C. No decrease in activity was observed after routine storage at -80 °C for 6 months.

Enzyme Assays

Catalase activity was measured spectrophotometrically by following the decrease in H2O2 concentration (epsilon 240 = 0.0435 mM-1 cm-1) (38) at 25 °C. The specific activity was determined at pH 7.0 (50 mM NaH2PO4) and 10 mM H2O2. Peroxidase activity was also determined spectrophotometrically by following the absorbance change for a number of different substrates: o-dianisidine (epsilon 460 = 11.3 mM-1 cm-1) (25); p-phenylenediamine at 500 nm (see Table III); pyrogallol (epsilon 430 = 2.47 mM-1 cm-1) (25); and NADH and NADPH (epsilon 340 = 6.2 mM-1 cm-1). The pH profiles were determined in the following buffers: 50 mM Na2HPO4, pH 8.09 and pH 7.50; 50 mM NaH2PO4, pH 7.00, 6.50, and 5.96; and 50 mM sodium acetate, pH 5.45, 4.44, and 3.73. 

Table III.

Peroxidase activity of KatG wild type and R463L mutant


Substrate Specific activity of wild typea Specific activity of R463La

o-Dianisidine 25.9  ± 1.9 22.8  ± 2.3
p-Phenylendiamineb 99.4  ± 5.1 100.7  ± 5
Pyrogallol 2.12  ± 0.13 2.29  ± 0.17
NADH 0.212  ± 0.04 0.208  ± 0.04
NADPH 0.272  ± 0.035 0.264  ± 0.035
Isoniazid (9.04  ± 1.3)  × 10-3 s (9.8  ± 1.3)  × 10-3 s

a  Specific activity is reported as units/mg KatG, where 1 unit is the amount of enzyme that converts 1 µmol of substrate/min under the conditions described under "Experimental Procedures," unless indicated otherwise.
b  Specific activity is defined as the change in A500/min/mg of KatG.

Isoniazid Oxidations

The oxidation of isoniazid by KatG was measured in 50 mM Na2HPO4, pH 7.5, containing 0.1 µM MnCl2 at 37 °C. Reactions were analyzed as described previously (10). Inactivation experiments of InhA in the presence of wild-type KatG and the R463L mutant of KatG were carried out in 100 mM Na2HPO4, pH 7.5, 0.1 mM MnCl2, 100 µM isoniazid, and 60 µM NADH at 25 °C. InhA and KatG concentrations were 1.2 and 3.0 µM, respectively. All reactions also contained 0.1 mg/ml acetylated bovine serum albumin and 8% (v/v) glycerol to maintain protein stability. Reaction aliquots were removed at defined times and analyzed for InhA activity utilizing the substrates 2-trans-octenoyl-CoA (30 µM) and NADH (75 µM). Rates were determined by following the decrease in concentration of NADH. The specific activity of InhA with 2-trans-octenoyl-CoA as a substrate at Vmax (pH 7.5, 25 °C) was about 7 µmol min-1 mg-1.

Spectroscopy

UV-visible spectra were recorded on a Uvicon 9310 spectrophotometer. All kinetic parameters were determined on a Uvicon 860 equipped with a circulating water bath for temperature control. X-band EPR spectra were recorded using a Varian E-109 spectrometer equipped with an E-102 microwave bridge and a liquid helium cryostat and Heli-Tran liquid helium transfer system (Air Products). The sample temperature was monitored with a gold-chrome thermocouple junction.

Additional Analytical Methods

The native molecular weight of KatG was determined by gel filtration with both a Sephadex G-200 column (26 × 550 mm) equilibrated with 50 mM NaH2PO4, pH 7.1, containing 200 mM NaCl, and a Superose 12HR 30/10 column equilibrated with 20 mM bis-Tris, pH 7, containing 150 mM NaCl. The molecular mass standards used included ferritin (440,000 Da), beef liver catalase (232,000 Da), bovine serum albumin (67,000 Da), and cytochrome C peroxidase (32,000 Da). Protein concentrations were determined colorimetrically utilizing bovine serum albumin as a standard (39). The heme content of the enzyme was determined as the pyridine ferrohemochrome by the method of Falk (40). Nondenaturing PAGE (41) and denaturing PAGE were carried out as described previously.


RESULTS

Expression and Purification of KatG

The mycobacterial katG gene was subcloned into the plasmid pRG to afford the plasmid pKATII, placing the wild-type katG downstream of the E. coli tryptophan promoter. The mutant pKATII R463L was subsequently prepared by a standard site-directed mutagenesis technique as described under "Experimental Procedures." E. coli UM262, a katG-deficient strain, was transformed with both pKATII and pKATII R463L, and a successful transformant of each was identified and grown on a 6-liter scale. Analysis of cell extracts after induction of expression showed that KatG migrates as two bands (termed KatGI and KatGII) on nondenaturing PAGE (Fig. 2). It has been previously observed that nondenaturing PAGE of cell extracts from M. tuberculosis cultures shows two bands with KatGI as the major component (6, 30). The ratio between KatGI and KatGII in cell extracts after induction of expression (determined by nondenaturing PAGE and activity staining) depends on the amount of supplementary Fe(NH4)2(SO4)2 added to the medium, with KatGI being the predominant band above a concentration of 0.5 mg/liters. The amount of catalase activity observed in these cell extracts also increased approximately 10-fold as the supplementary iron concentration was increased from 0 to 5 mg/liter Fe(NH4)2(SO4)2.


Fig. 2. Native PAGE of KatG. The gel was stained for peroxidase activity as described under "Experimental Procedures." One to five µg of protein were loaded per lane. Lane a, crude KatG before Mono Q column; lane b, KatGII (after final Mono Q column); lane c, sample composed of predominantly KatGI (after final Mono Q column).
[View Larger Version of this Image (46K GIF file)]


Expression of KatG and subsequent purification by standard protein purification techniques yielded approximately 3 mg of active enzyme (KatGI)/liter of shake flask culture (Table I). KatGI was resolved from KatGII in the final high resolution chromatographic step of the purification protocol and possessed a significantly higher RZ (A408/A280 = 0.69) compared with samples composed of predominantly KatGII (A408/A280 = 0.4), suggesting that the heme content of KatGII is significantly lower. The sequence of the first five N-terminal amino acids was confirmed by Edman degradation and showed that the N-terminal methionine is cleaved from the protein. Nondenaturing PAGE of the KatG preparation stained for peroxidase activity is shown in Fig. 2. The enzyme runs as a single band of approximately 82 kDa (purity >90%) on SDS-PAGE (Coomassie Blue staining). In addition to the major 82 ± 3-kDa band, a fragment about 5 kDa smaller was seen in SDS-PAGE of samples composed of predominantly KatGII, presumably proteolytically degraded KatG. These results suggest that KatGII arises from insufficient in vivo concentrations of cofactor and/or proteolytic degradation. All the following physical and kinetic characterization of KatG was done with samples composed of KatGI. Expression levels and purification properties of the KatG R463L mutant were similar to wild-type KatG.

Table I.

Summary of the purification of KatG

Purification from a 6-liter shake flask culture of E. coli UM262 containing pKATII grown as described under "Experimental Procedures" is shown.
Step Total protein Total catalasea Specific catalase Recovery Purification

mg units × 10-3 units/mg % -fold
CFE 2124 481 226 100 1
(NH4)2SO4 precipitation 1161 402 346 83.5 1.5
DEAE-Sephacel 212 233 1100 48.5 4.9
S200 Superdex 77.5 142 1838 29.6 8.1
Mono Q 17.7 42 2420 8.9 10.7

a  One unit of catalase activity is the amount of enzyme that catalyzes the disproportionation of 1 µmol of H2O2/min.

Physical Characterization of KatG

The native molecular weight of KatG was determined by gel filtration chromatography on Sephadex G200 and Superose 12HR columns. The measured apparent molecular mass was 175 and 161 kDa, respectively, indicating that the protein forms a dimer in solution. This is in agreement with the value obtained for KatG isolated from cell extracts from M. tuberculosis (42). The heme content of native KatG was determined through the pyridine hemochrome spectrum, which exhibited the typical peaks of iron protoporphyrin IX, with maxima at 419, 525, and 556 nm (data not shown). Based on a value of epsilon 556 = 33,200 M-1 cm-1 for pyridine hemochrome (40), the heme content of the enzyme was calculated to be 0.98 heme/dimer. This stoichiometry is consistent with the relatively low A408/A280 ratio of 0.69 and agrees well with other catalase-peroxidases of this class.

The visible absorption spectrum of native KatG exhibited maxima at 408, 490, and 627 nm (Fig. 3). These values for the Soret and overlapping alpha  and beta  absorption bands are similar to those of horseradish peroxidase (43, 44) and aquomet myoglobin (45), both high spin heme proteins with histidine as the proximal ligand. In addition, the absorption band at 627 nm is a more general characteristic of high spin ferric heme proteins, including catalase (46) and cytochrome P450cam (47). The native protein can be reduced with sodium dithionite, yielding new maxima at 440 and 559 nm (Fig. 3). Reduction by sodium dithionite is characteristic of catalase-peroxidases, in contrast to catalase, which is not reducible with sodium dithionite (46). The addition of potassium cyanide (10 mM) to the ferric KatG shifts the Soret band to 425 nm and leads to an additional maximum at 545 nm with a broad shoulder at 575 nm (Fig. 3). The changes in the optical spectrum associated with the binding of a cyanide anion to the catalase-peroxidase are all similar to those observed in the six-coordinate cyanide complexes of horseradish peroxidase (43, 44) and metmyoglobin (45) and are consistent with the conversion of high spin ferric heme to a low spin configuration. This spectrum is distinct from that of the low spin ferric cyanide complex of cytochrome P450cam, which possesses a thiolate proximal ligand (47). The visible absorption spectra of the KatG R463L mutant were identical with wild-type KatG catalase-peroxidase.


Fig. 3. Absorption spectrum of wild-type KatG in 50 mM Na2HPO4, pH 7, 25 °C. ------, native KatG; ···, KatG plus 4 mM sodium dithionite; - - -, KatG plus 10 mM KCN.
[View Larger Version of this Image (17K GIF file)]


The low temperature EPR spectrum of the ferric form of wild-type KatG is shown in Fig. 4A. The spectrum is complex, exhibiting multiple g values, which for an enzyme with one heme indicates the presence of a thermal equilibrium of spin configurations and, additionally, the possible ligation of either water or some active site ligand (e.g. a distal histidine) induced by freezing. The spectrum is composed of at least two high spin ferric signals with a rhombic component having resonances at g = 6.07, 5.19, and 1.94, and g = 5.73, 4.71, and 1.94, and possibly an additional high spin signal with a g value at 5.50. In addition to the high spin signals, two low spin signals are also present, both of which have their low field feature in the g = 3.0 region. The spectrum of wild-type KatG in the presence of 200 mM sodium formate (Fig. 4C) shows that the native enzyme has been converted to a single major rhombic, high spin species with g = 5.70, 4.73, and 1.94. This type of ferric high spin signal is characteristic of catalase-peroxidases (20, 21, 25) and is similar to the more highly defined rhombic, ferric high spin signals of catalase (46) and horseradish peroxidase (43, 44). The spectrum of the cyanide (30 mM) adduct of wild-type KatG (Fig. 4D) shows a single low spin signal with g = 3.04 and 2.11. The spectra of these species are typically very temperature-sensitive, with the low field feature of low spin heme usually the sharpest feature in the spectrum. The derivative-shaped crossing and high field down features are usually broad and, therefore, more difficult to observe even at these low temperatures (48). In addition to the major low spin resonance, there is a small residual high spin signal and a small resonance in the g = 4.3 region attributable to adventitiously bound ferric ions. The presence of this low spin signal is also characteristic of the cyanide adduct of horseradish peroxidase and distinctly different from the ferric low spin signal of the cytochrome P450cam cyanide adduct (49). Furthermore, the presence of either one predominant high spin ferric heme-formate EPR signal or one axial low spin heme-cyanide EPR signal clearly indicates that wild-type KatG contains only one type of heme, consistent with the heme/protein stoichiometry determined above. The EPR spectra of the KatG R463L mutant (Fig. 4B) were virtually identical to that of wild-type KatG.


Fig. 4. Low temperature EPR spectra of wild-type KatG and the KatG R463L mutant. A, native wild-type KatG (120 µM) in 20 mM MOPS, pH 7.5, 40% glycerol. B, native KatG R463L mutant (128 µM) in 20 mM MOPS, pH 7.5, 40% glycerol. C, wild-type KatG (78 µM) plus 200 mM sodium formate, pH 7.0. D, wild-type KatG (78 mM) plus 30 mM KCN, pH 7.0. Conditions in A, B, and C were as follows: microwave frequency, 9.193 GHz; microwave power, 10 mW; modulation amplitude, 10 G; modulation frequency, 100 kHz; time constant, 0.25 s; temperature, 5 K. Conditions in D were as follows: microwave frequency, 9.184 GHz; microwave power, 20 mW; modulation amplitude, 32 G; modulation frequency, 100 kHz; time constant, 0.25 s; temperature, 20 K.
[View Larger Version of this Image (14K GIF file)]


Catalase and Peroxidase Activity of KatG

KatG possesses high catalase activity (Table II). As with other catalase-peroxidases, the activity shows a significant pH dependence, with a maximum activity at pH 7.0 (Fig. 5). In contrast, the maximum activity of monofunctional catalases plateaus over several pH units (13). The differences in the pH profiles of catalase and peroxidase activity could be a function of either general differences in the reactivities of the different substrates (indicated also by the observation that different peroxidase substrates show different pH profiles) or differences in the pH dependence of the intrinsic enzymic activities. A similar difference in the pH profiles of the catalase and peroxidase activities has been observed for the catalase-peroxidase from Klebsiella pneumoniae (16).

Table II.

Catalase activity of KatG wild type and R463L mutant


Enzyme kcat Km kcat/Km

s-1 mM M-1 s-1 s-1
Wild type (1.01  ± 0.15)  × 104 5.18  ± 0.8 (1.95  ± 0.12)  × 106
R463L (1.14  ± 0.15)  × 104 6.16  ± 0.7 (1.85  ± 0.1)  × 106


Fig. 5. pH profile for catalase and peroxidase activity of KatG. Conditions were as described under "Experimental Procedures." bullet , catalase activity; open circle , peroxidase activity, o-dianisidine; triangle , peroxidase activity, NADPH.
[View Larger Version of this Image (18K GIF file)]


KatG displays saturation kinetics with an apparent Km of 5.2 mM for H2O2. The observed kcat/Km for KatG catalase activity is 1.95 × 106 M-1 s-1, 1 order of magnitude below that of beef liver catalase (50) and roughly 3 orders of magnitude below the diffusion controlled limit. The specific catalase activity of the recombinant KatG reported here is roughly 6-fold higher than that of "native" KatG purified from M. tuberculosis cell extracts (42) and approximately 150-fold higher than that from M. tuberculosis H37Rv (55). These differences are most likely due to the difficulty of purifying KatG from cell extracts of the natural host as well as significant differences in the purification protocol utilized; for example, these enzymes are known to undergo an "aging" process dependent on how the purified enzyme is handled and stored. (A similar difference was observed for the specific peroxidase activity with o-dianisidine as the substrate for recombinant KatG versus native KatG purified from M. tuberculosis H37Rv cell extracts (55).) The kinetic constants for the catalase activity of the KatG R463L mutant showed no significant differences in comparison with the wild-type enzyme (Table II).

KatG also possesses significant peroxidase activity with several substrates (Table III). The pH profiles of the specific activity of KatG with the substrates, o-dianisidine and NADPH, are shown in Fig. 5. The activity with o-dianisidine as a substrate at pH 5.45 is roughly 800-fold lower than that of the monofunctional horseradish peroxidase (16). This might reflect the direct competition between catalase and peroxidase activities in catalase-peroxidases because the activated enzyme can be either reduced by the peroxidase substrate or H2O2. In addition, the high catalase activity leads to a rapid depletion of H2O2, especially at the pH of maximum catalase activity. As with other catalase-peroxidases, KatG accepts both NADH and NADPH as electron donors, although at slightly lower rates than have been reported for other catalase-peroxidases (about 6-fold slower than the E. coli enzyme and 4-fold slower than the K. pneumoniae enzyme) (16). There were no significant differences in the activity of the KatG R463L mutant relative to wild-type KatG with any of these substrates.

In addition to traditional peroxidase substrates, wild-type KatG and the KatG R463L mutant both oxidize the antituberculosis drug isoniazid, forming isonicotinic acid as the major product (10). Both the isoniazid and catalase activities of KatG and the R463L mutant were measured from 20 to 100 µM isoniazid and displayed the same dependence on isoniazid concentration (higher concentrations of isoniazid result in degradation of the heme). No H2O2 has to be added to the reaction mixture, since the oxidation proceeds efficiently even in the absence of H2O2. This is indicative of a radical chain reaction and can be rationalized considering that the reaction should produce peroxides (such as isonicotinic peracid or H2O2), which in turn can activate KatG (10). The reaction in the assay system can be initiated through Mn(II)-catalyzed autoxidation of isoniazid; autoxidation has been shown to produce peroxides in previous studies (51). The rate and product composition of the enzyme-catalyzed oxidation as well as the autoxidation of isoniazid greatly depend on the assay conditions, such as pH, buffer composition, and the presence of metals. The situation inside M. tuberculosis, however, might vary considerably from our assay system, because the metabolic activity of bacteria as well as the human defense system (particularly the macrophage) produce a constant stream of peroxides. Furthermore, other enzymes such as the alkylhydroperoxidase AhpC (29) or other substrates might compete for the peroxides. Despite the possible differences between the in vivo and in vitro conditions, it is clear that wild-type KatG and the R463L mutant of KatG possess comparable activities against isoniazid.

Inactivation of InhA by KatG-activated Isoniazid

It has previously been shown that oxidation of isoniazid by KatG in the presence of InhA leads to the inactivation of InhA (12). Based on this as well as other biochemical and genetic evidence described above, it has been proposed that this sequence of steps represents the fundamental mechanism of action of isoniazid. Therefore, the in vitro assay gives us the opportunity to directly test the capability of KatG mutants to mediate the inactivation of InhA. The inactivation of InhA as a function of time in the presence of either wild-type KatG or R463L mutant of KatG is shown in Fig. 6. Consistent with the spectroscopic and kinetic results described above, there is no significant difference in the behavior of the two enzymes; both efficiently mediate the inactivation of InhA by isoniazid.


Fig. 6. Inactivation of InhA during the KatG-catalyzed oxidation of isoniazid. Conditions were as described under "Experimental Procedures." bullet , wild-type KatG; open circle , R463L; triangle , no KatG.
[View Larger Version of this Image (17K GIF file)]



DISCUSSION

The catalase-peroxidase KatG from M. tuberculosis plays a central role in the mechanism of action of the antituberculosis drug isoniazid and, therefore, the development of one type of isoniazid-resistance, all due, ironically, to its natural role as a component of mycobacterial virulence. Previous attempts to purify sufficient amounts of protein for detailed studies from cultures of M. tuberculosis were hampered by the slow growth of the bacterium and its contagious nature. Although we and others have already reported preliminary results on the expression of KatG from M. tuberculosis in E. coli and on some catalytic properties of the enzyme, we present here a more detailed study on the spectroscopic and kinetic properties of recombinant KatG from M. tuberculosis and a mutant of KatG frequently found in isoniazid-resistant strains. Overexpression of KatG in E. coli, utilizing the expression plasmid pKATII, has allowed the purification of sufficient protein to allow us to carry out the spectroscopic and kinetic studies described here.

Physical characterization of KatG clearly indicates that it is one of a developing class of bacterial enzymes that catalyze both catalase- and peroxidase-like reactions. Optical absorption and EPR spectra are consistent with what has been previously observed for this class of enzymes and suggest that KatG, like horseradish peroxidase and myoglobin, contains a histidine as the proximal ligand. This is supported by sequence alignment of several catalase-peroxidases of this class (including M. tuberculosis) and the high resolution crystal structure of cytochrome C peroxidase, which indicates the presence of a conserved histidine on both the distal and proximal side of the active site heme (23). The source of the complexity of the native KatG EPR spectrum is unclear. The addition of the weak field ligand formate, however, converts the complex spectrum to one predominant high spin feature. Moreover, the addition of a strong field ligand like cyanide leads to an almost complete conversion to a single low spin species. Since conversion to the low spin signal by cyanide results in a single rhombic EPR signal, the more complex high spin signal arises from local environmental perturbations in a single type of heme prosthetic group in KatG.

KatG from M. tuberculosis, as is characteristic of other catalase-peroxidases, is a very efficient catalase, with a kcat/Km of about 2 × 106 M-1 cm-1. In addition to its catalase activity, KatG functions as a broad specificity peroxidase, oxidizing various electron donors, including NAD(P)H. It has been argued that the oxidation of NAD(P)H by catalase-peroxidases points to a metabolic role of these enzymes (16, 25), specifically, that the in vivo oxidation of the pyridine nucleotides would provide some sort of regulatory role in controlling overall metabolic rates through the control of the ratio of reduced to oxidized cofactor. In monofunctional catalases, it is believed that the tightly bound NADPH functions as a safety net protecting the enzyme against an accumulation of compound I (52). However, a recent analysis of isoniazid-sensitive and -resistant strains of M. tuberculosis has suggested an alternative explanation for the peroxidase activity of KatG. It has been demonstrated that expression of KatG protects M. tuberculosis against H2O2 as well as organic peroxides (29). In isoniazid-resistant strains, loss of catalase-peroxidase activity can be partially compensated for by a second mutation that results in hyperexpression of AhpC, an alkylhydroperoxidase that can protect the bacterium against organic peroxides (29). This suggests that the detoxification of organic peroxides is an important task of KatG from M. tuberculosis, since it helps the highly adapted pathogen to survive within host macrophages. According to this hypothesis, organic peroxides could be reduced by catalase-peroxidases to the corresponding alcohols with formation of compound I. The transformation of compound I back to the resting state of the enzyme can be accomplished through either the catalase or peroxidase pathway (Fig. 1). The peroxidase activity of KatG against NAD(P)H thus could ensure efficient detoxification of organic peroxides in the absence of sufficient concentrations of H2O2. This hypothesis will require more detailed studies with a variety of alkylperoxides as substrates.

Another main objective of this study was to characterize the R463L mutant of KatG, a mutation that has been found in roughly 30-50% of all analyzed isoniazid-resistant strains. KatG R463L exhibits identical visible absorption and EPR spectra to wild-type KatG. The KatG R463L mutant also possesses the same catalytic activity with H2O2 as well as a number of other typical peroxidase substrates, including NADH/NADPH. More importantly, both wild-type KatG and the R463L mutant of KatG oxidize isoniazid and mediate the inactivation of InhA with about the same efficiency. These findings are not consistent with previous suggestions that the R463L mutation of KatG might allow KatG to discriminate against isoniazid as a substrate. It should be noted, however, that these results must be interpreted with caution. The in vivo conditions of the mycobacterial cell are unknown and are certainly different from those conditions typical of an in vitro assay. It is conceivable, for example, that KatG R463L could have a higher activity against an as yet unidentified substrate that could be competitive with isoniazid for the activated form of the catalase-peroxidase. It is also possible that the R463L mutant of KatG has nothing to do directly with substrate binding but rather leads to a change in protein-protein interactions within the bacterium that indirectly influences the rate of inactivation of InhA or an additional target sensitive to activated isoniazid (9). Our findings are, however, in agreement with the recent suggestion that the R463L mutation of KatG is a frequent polymorphism and does not affect isoniazid sensitivity. A solid demonstration of the role of the R463L mutant of KatG must await future experiments with isogenic strains of M. tuberculosis.


FOOTNOTES

*   The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Dagger    Supported by a Forschungsstipendium of the Deutsche Forschungsgemeinschaft.
§   Present address: Lehrstuhl für Organische Chemie I, Ruhr-Universität Bochum, 44780 Bochum, Germany.
   Recipient of the Alexander Hollaender Distinguished Postdoctoral Fellowship from the United States Department of Energy.
par    Howard Hughes Medical Institute Investigator; supported by National Institutes of Health Grant R01GM49220. To whom correspondence should be addressed. Tel.: 510-642-9277; Fax: 510-643-6890.
1    It should be noted, however, that not all isoniazid-resistant strains of M. tuberculosis show a loss of peroxidase activity. Alternative resistance mechanisms include mutations leading to overexpression of InhA or mutations in the InhA enoyl-acyl carrier protein reductase (54) and other as yet unidentified mechanisms (32).
2    The abbreviations used are: MOPS, 3-(N-morpholino)propanesulfonic acid; PAGE, polyacrylamide gel electrophoresis.

Acknowledgments

We acknowledge Drs. S. Cole, J. S. Blanchard, P. Loewen, and S.-H. Kim for the generous gifts of protein and plasmids. We also thank Dr. M. P. Klein and Dr. V. K. Yachandra of the Structural Biology Division, Lawrence Berkeley Labs, for use of an EPR spectrometer and for valuable assistance, and we thank S. Zhou for protein sequence analysis.


REFERENCES

  1. Bloom, B. R., and Murray, C. J. L. (1992) Science 257, 1055-1064 [Medline] [Order article via Infotrieve]
  2. Kochi, A. (1991) Tubercule 72, 1-6 [Medline] [Order article via Infotrieve]
  3. Frieden, T. R., Sterling, T., Pablos-Mendez, A., Kilburn, J. O., Cauthen, G. M., and Dooley, S. W. (1993) N. Engl. J. Med. 328, 522-525
  4. Kaufman, S., and van Embden, J. (1993) Trends Microbiol. 1, 2-5 [Medline] [Order article via Infotrieve]
  5. Young, D. B. (1994) Curr. Biol. 4, 351-353 [Medline] [Order article via Infotrieve]
  6. Zhang, Y., Heym, B., Allen, B., Young, D., and Cole, S. (1992) Nature 13, 591-593
  7. Banerjee, A., Dubnau, E., Quémard, A., Balasubramanian, V., Um, K. S., Wilson, T., Collins, D., de Lisle, G., and Jacobs, W. R., Jr. (1994) Science 263, 227-230 [Medline] [Order article via Infotrieve]
  8. Quémard, A., Sacchettini, J. C., Dessen, A., Vilcheze, C., Bittman, R., Jacobs, W. R., Jr., and Blanchard, J. S. (1995) Biochemistry 34, 8235-8241 [Medline] [Order article via Infotrieve]
  9. Mdluli, K., Zhu, Y., Crane, D. C., and Barry, C. E., III (1996) Proceedings of the US-Japan Tuberculosis Research Conference, Nagasaki, Japan
  10. Johnsson, K., and Schultz, P. G. (1994) J. Am. Chem. Soc. 116, 7425-7426
  11. Shoeb, H. A., Bowman, B. U., Ottolenghi, A. C, and Merola, A. J. (1985) Antimicrob. Agents Chemother. 27, 404-407 [Medline] [Order article via Infotrieve]
  12. Johnsson, K., King, D. S., and Schultz, P. G. (1995) J. Am. Chem. Soc. 117, 5009-5010
  13. Nadler, V., Goldberg, I., and Hochman, A. (1986) Biochim. Biophys. Acta 882, 234-241
  14. Clairborne, A., and Fridovich, I. (1979) J. Biol. Chem. 254, 4245-4252 [Abstract]
  15. Loprasert, S., Negoro, S., and Okada, H. (1988) J. Gen. Microbiol. 134, 1971-1976 [Medline] [Order article via Infotrieve]
  16. Hochman, A., and Goldberg, I. (1991) Biochim. Biophys. Acta 1077, 299-307 [Medline] [Order article via Infotrieve]
  17. Fukumori, Y., Fujiwara, T., Okada-Takahashi, Y., Mukohata, Y., and Yamanaka, T. (1985) J. Biochem. 98, 1055-1061 [Abstract]
  18. Hochman, A., and Shemesh, A. (1987) J. Biol. Chem. 262, 6871-6876 [Abstract/Free Full Text]
  19. Forkl, H., Vandekerckhove, J., Drews, G., and Tadros, M. H. (1993) Eur. J. Biochem. 214, 251-258 [Abstract]
  20. Youn, H.-D., Yim, Y.-I., Kim, K., Hah, Y. C., and Kang, S.-O. (1995) J. Biol. Chem. 270, 13740-13747 [Abstract/Free Full Text]
  21. Cendrin, F., Jouve, H. M., Gaillard, J., Thibault, P., and Zaccai, G. (1994) Biochim. Biophys. Acta 1209, 1-9 [Medline] [Order article via Infotrieve]
  22. Yumoto, I., Fukumori, Y., and Yamanaka, T. (1990) J. Biochem. 108, 583-587 [Abstract]
  23. Mutsuda, M., Ishikawa, T., Takeda, T., and Shigeoka, S. (1996) Biochem. J. 316, 251-257 [Medline] [Order article via Infotrieve]
  24. Fraaije, M. W., Roubroeks, H. P., Hagen, W. R., and Van Berkel, W. J. H. (1996) Eur. J. Biochem. 235, 192-198 [Abstract]
  25. Marcinkeviciene, J. A., Magliozzo, R. S., and Blanchard, J. S. (1995) J. Biol. Chem. 270, 22290-22295 [Abstract/Free Full Text]
  26. Nagy, J. M., Cass, A. E. G., and Brown, K. A. (1995) Biochem. Soc. Trans. 23, 152S [Medline] [Order article via Infotrieve]
  27. Hillar, A., and Loewen, P. C. (1995) Arch. Biochem. Biophys. 323, 438-446 [CrossRef][Medline] [Order article via Infotrieve]
  28. Wilson, T., de Lisle, G. W., and Collins, D. M. (1995) Mol. Microbiol. 15, 1009-1015 [Medline] [Order article via Infotrieve]
  29. Sherman, D. R., Mdluli, K., Hickey, M. J., Arain, T. M., Morris, S. L., Barry, C. E., III, and Stover, C. K. (1996) Science 272, 1641-1643 [Abstract]
  30. Heym, B., Alzari, P. M., Honore, N., and Cole, S. T. (1995) Mol. Microbiol. 15, 235-245 [Medline] [Order article via Infotrieve]
  31. Rouse, D. A., Li, Z., Bai, G.-H., and Morris, S. (1995) Antimicrob. Agents Chemother. 39, 2472-2477 [Abstract]
  32. Morris, S., Bai, H. G., Suffys, P., Portillo-Gomez, L., Fairchok, M., and Rouse, D. (1995) J. Infect. Dis. 171, 954-960 [Medline] [Order article via Infotrieve]
  33. Cockerill, F. R., Uhl, J. R., Temegren, Z., Zhang, Y., Stockman, L., Roberts, G. D., Williams, D. L., and Kline, B. C. (1995) J. Infect. Dis. 171, 240-245 [Medline] [Order article via Infotrieve]
  34. Musser, J. M., Kapur, V., Williams, D., Kreiswirth, B. N., van Solingen, D., and van Embden, J. D. A. (1995) J. Infect. Dis. 173, 196-202
  35. Loewen, P. C., Switala, J., Smolenski, M., and Triggs-Raine, B. L. (1990) Biochem. Cell Biol. 68, 1037-1044 [Medline] [Order article via Infotrieve]
  36. Chung, H.-H. (1993) Ph.D. thesis, University of California, Berkeley, CA
  37. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd Ed., Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  38. Hildebranlt, A. G., and Roots, I (1975) Arch. Biochem. Biophys. 171, 385-387 [Medline] [Order article via Infotrieve]
  39. Bradford, M. M. (1976) Anal. Biochem. 72, 248-254 [CrossRef][Medline] [Order article via Infotrieve]
  40. Falk, J. K. (1964) in Porphyrins and Metalloporphyrins (Smith, K. M., ed), pp. 804-807, Elsevier Publishing Co., New York
  41. Wayne, L. G., and Diaz, G. A. (1986) Anal. Biochem. 157, 89-92 [Medline] [Order article via Infotrieve]
  42. Diaz, G. A., and Wayne, L. G. (1974) Am. Rev. Respir. Dis. 110, 312-319 [Medline] [Order article via Infotrieve]
  43. Rakhit, G., and Spiro, T. G. (1974) Biochemistry 13, 5317-5323 [Medline] [Order article via Infotrieve]
  44. Dunford, H. B., and Stillman, J. S. (1976) Coord. Chem. Rev. 19, 187-251 [CrossRef]
  45. Antonini, E., and Brunori, M. (1971) Hemoglobin and Myoglobin in Their Reaction with Ligands, North-Holland Publishing Co., Amsterdam
  46. Jacob, G. S., and Orme-Johnson, W. H. (1979) Biochemistry 18, 2967-2975 [Medline] [Order article via Infotrieve]
  47. Sato, R., and Omura, T. (1978) Cytochrome P-450, Academic Press, Inc., New York
  48. Palmer, G. (1983) Iron Porphyrins (Lever, A. B. P., and Gray, H. B., eds) Part II, pp. 43-88, Addison-Wesley, Reading, MS
  49. Lipscomb, J. D. (1980) Biochemistry 19, 3590-3599 [Medline] [Order article via Infotrieve]
  50. Ogura, Y. (1955) Arch. Biochem. Biophys. 96, 288-300
  51. Ito, K., Yamamoto, K., and Kawanishi, S. (1992) Biochemistry 31, 11606-11613 [Medline] [Order article via Infotrieve]
  52. Kirkmann, H. N., and Gaetani, G. F (1985) Proc. Natl. Acad. Sci. U. S. A. 81, 4343-4347
  53. Pretorius, G. S., van Helden, P. D., Sirgel, F., Eisenach, K. D., and Victor, T. C. (1995) Antimicrob. Agents Chemother. 39, 2276-2281 [Abstract]
  54. Dessen, A., Quémard, A., Blanchard, J. S., Jacobs, W. R., Jr., and Sacchettini, J. C. (1995) Science 267, 1638-1641 [Medline] [Order article via Infotrieve]
  55. Devi, B. G., Shaila, M. S., Ramakrishnan, T., and Gopinathan, K. P. (1975) Biochem. J. 149, 187-197 [Medline] [Order article via Infotrieve]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.